Princess Beatrix Muscle Foundation Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2005
NCT00136110
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Princess Beatrix Muscle Foundation

Active Ingredients

Drugs in Phase 3 Trials (2)

phenytoin (mesantoin) (1 trial)

valproic acid (depakene) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Amyotrophic Lateral Sclerosis (Phase 3)

Motor Neuron Disease (Phase 3)

Polyneuropathies (Phase 3)

Sclerosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2